Needle enables safe drug reconstitution and transfer.August 3, 2006 -
Measuring 4 mm long, CyTwo-Fer(TM) Needle has hub design that allows for vented vial access and non-vented IV bag access. It is designed for use with smaller vials, permitting users to draw up reconstituted drug trapped in vial neck. Without changing needles, product allows bag and vial access in one procedure. It features 16G stainless steel cannula with tapered Huber point. Also included, 0.2 micron vent filter helps prevent contamination during hazardous drug reconstitution.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Baxa Corp.
14445 Grassland Dr
Englewood, CO, 80112
USA
Baxa Ltd. Launches New CyTwo-Fer(TM) Needle for Safe Drug Reconstitution and Transfer
ASCOT, England, June 26 -- Baxa Ltd. announces the launch of the new CyTwo-Fer Needle in a 4 mm length. Like the existing 16 mm product, it features a unique hub design that allows vented vial access and non-vented IV bag access, performing the work of two devices. This shorter CyTwo-Fer Needle is designed for use with smaller vials, permitting users to draw up reconstituted drug trapped in the vial neck, avoiding wastage of expensive medications. Both CyTwo-Fer Needles allow bag and vial access in one procedure, facilitating the movement of drugs from one container to another without the time and expense of changing needles.
"Following our success with the 16 mm CyTwo-Fer Needle, we were encouraged to develop a 4 mm version to meet market demand for a short needle, which is suited to small vials and avoids wastage of expensive drugs," says Brendan Parker, Director of Sales and Marketing for Baxa Ltd. CyTwo-Fer Needles feature a 16G stainless steel cannula with a tapered Huber point for smooth and safe vial access, without the coring often associated with plastic spike devices. The Huber point also allows users to direct liquid flow into the vial, reducing foaming during admixture and preventing damage to delicate biotech and protein-based drugs.
Designed to prevent contamination during hazardous drug reconstitution, CyTwo-Fer Needles feature a 0.2 micron vent filter, facilitating efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices without risk of blowback or drug aerosolization. The integrated vent balances air pressure in the vial or container for fast and easy liquid addition and removal, minimising the risk of upper limb disorder. Finger grips and a tethered cap make the device easy to use.
CyTwo-Fer Needles are available for sale now in Europe, the Middle East and Africa -- directly through Baxa Ltd. or through distributor representatives. For more information, visit the product section of www.baxa.com, or contact Baxa Ltd.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at www.baxa.com.
Contact:
Stephanie Scott, Marketing Manager, Baxa Ltd.
Tel: +44(0)1344-890916 or Fax: +44(0)1344-890917
email: s.scott@baxa.co.uk
|
|
|
|
|
|
|
| 
